Výsledky vyhledávání - "Bismuth-containing quadruple regimen"

Akademický článek

Efficacy comparison of 7- and 14-day P-CAB based bismuth-containing quadruple regimen with PPI based bismuth-containing quadruple regimen for Helicobacter pylori infection: rationale and design of an open-label, multicenter, randomized controlled trial.

Autor: Oh, Chang Kyo^1,2 (AUTHOR), Lim, Hyun^2,3 (AUTHOR) hlim77@hallym.or.kr, Seo, Seung In^2,4 (AUTHOR), Lee, Sang Pyo^2,5 (AUTHOR), Bang, Chang Seok^2,6 (AUTHOR), Shin, Woon Geon^2,4 (AUTHOR), Kim, Jin Bae^1,2 (AUTHOR), Jang, Hyun Joo^2,5 (AUTHOR), Baik, Gwang Ho^2,6 (AUTHOR)

Publikováno v: BMC Gastroenterology. 12/21/2023, Vol. 23 Issue 1, p1-7. 7p.

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Autor: Chang Kyo Oh, Hyun Lim, Seung In Seo, Sang Pyo Lee, Chang Seok Bang, Woon Geon Shin, Jin Bae Kim, Hyun Joo Jang, Gwang Ho Baik

Publikováno v: BMC Gastroenterology, Vol 23, Iss 1, Pp 1-7 (2023)

Abstract Background Owing to its strong acid inhibition, potassium-competitive acid blocker (P-CAB) based regimens for Helicobacter pylori (H. pylori) eradication are expected to offer clinical advantages over proton pump inhibitor (PPI) based regime

Externí odkaz: https://doaj.org/article/f254b86851da46bab50f53c8b07f6141

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

THE CLINICAL CHARACTERISTICS, ENDOSCOPIC FINDINGS AND THE EFFICACY OF THE BISMUTH-CONTAINING QUADRUPLE REGIMEN INTREATMENT OF PATIENTS WITH HELICOBACTER PYLORIGASTRODUODENAL INFLAMMATORY AND ULCER AT CAN THO HOSPITAL OF UNIVERSITY OF MEDICINE AND PHARMACY

Autor: Nhung Thai Thi Hong, Tam Huynh Hieu

Publikováno v: Journal of Medicine and Pharmacy. :7-12

Background: Helicobacter pylori causes inflammation of the gastric mucosa and is associated with many upper gastrointestinal diseases, including chronic gastritis, peptic ulcer disease and gastric cancer. The treatment of Helicobacter pylori still re

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::12fd4efa85dc9490c90a54e72228bbf1
https://doi.org/10.34071/jmp.2020.3.1

Zobrazit plný text záznamu

THE EFFICACY OF THE BISMUTH-CONTAINING QUADRUPLE REGIMEN IN HELICOBACTER PYLORI INFETION

Autor: Thi Khanh Tuong Tran, Quoc Bao Vu

Publikováno v: Journal of Medicine and Pharmacy. :29-34

Background and Objectives: Bismuth-containing quadruple regimen is recommended as an first-line therapy in areas with high clarithromycin and metronidazole resistance as well as an option for patients who have previously failed to respond to Helicoba

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e053069ebfe2ae80eea7a1d8ee4e2ec1
https://doi.org/10.34071/jmp.2017.3.4

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

CHRONIC HELICOBACTER PYLORI GASTRITIS: THE ERADICATION EFFICACY&NBSP;OF THE&NBSP;BISMUTH-CONTAINING QUADRUPLE REGIMEN (EBMT)

Autor: Ngoc Quy Hue Dang, Van Huy Tran, Thanh Hai Nguyen

Publikováno v: Journal of Medicine and Pharmacy. :149-158

Background: there has not been yet any research on the effectiveness of H. pylori eradication of bismuth-containing quadruple regimen on chronic gastritis patients in our country. Objective: to evaluate H. pylori eradication rate of bismuth-containin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::41992de1cfb2757c7b75cb6aa67dd36c
https://doi.org/10.34071/jmp.2016.2.21

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

STUDY OF HELICOBACTER PYLORI ERADICATON RATE OF BISMUTH-CONTAINING QUADRUPLE REGIMEN IN PATENTS WITH CHRONIC GASTRITS

Autor: Van Huy Tran, Thi Minh Trieu Nguyen

Publikováno v: Journal of Medicine and Pharmacy. :31-35

Background: Quadruple therapy with bismuth was considered as a promising regimen in the eradication of Helicobacter pylori in the population with clarithromycine- resistant high rate, but data in Vietnam was still limited. This study is aimed at dete

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::db77f141a9e19f5fcd5cade5f2ad46e6
https://doi.org/10.34071/jmp.2016.3.5

Zobrazit plný text záznamu

Third-Line Rescue Therapy with Bismuth-Containing Quadruple Regimen After Failure of Two Treatments (with Clarithromycin and Levofloxacin) for H. pylori Infection

Autor: B. Sacristán, Manuel Castro-Fernandez, Alicia Algaba, Ángeles Pérez-Aisa, Ines Modolell, Luis Rodrigo, Jesus Barrio, Rosario Anton, M. Gonzalez-Barcenas, Angel Cosme, Adrian G. McNicholl, Yamal Harb, Javier P. Gisbert, Javier Molina-Infante, Fernando Bermejo, Miguel Fernández-Bermejo, Alicia C Marin

Publikováno v: Digestive Diseases and Sciences. 59:383-389

Helicobacter pylori eradication therapy with a proton pump inhibitor (PPI), clarithromycin, and amoxicillin fails in >20 % of cases. A rescue therapy with PPI–amoxicillin–levofloxacin still fails in >20 % of patients. To evaluate the efficacy and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fc3533ea5995ea09f31b99a3ce7b8c6
https://doi.org/10.1007/s10620-013-2900-x

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání